Plasma Therapy Market - Platelet-rich Plasma may Help Aid Covid-19

The plasma therapy market is likely to gain momentum in the coming years on account of the increasing cases of sports injuries worldwide. Platelet-Rich Plasma (PRP) injections emerged as a regenerative medicine for enhancing the self-healing ability of the body and this is likely to help the market gain further popularity.

The current COVID-19 pandemic further helped expand the market owing to the lack of antiviral therapies and the fact that plasma therapy comes under an emergency treatment method. Besides this, the increasing use of platelet-rich plasma for different therapeutic procedures will also boost the growth of the market in the coming years.

Get Brochure of the Report @

Heavy Investments on Clinical Trials for Fighting COVID-19 by Manufacturers to Promote Market Growth

The U.S. Food and Drug Administration have been witnessing a tremendous rise in the number of clinical trials since the past few months. Various manufacturers operating in the plasma therapy market are investing heavily in research and development, clinical trials in the hope of coming up with an antivirus to fight corona. For instance, in October 2020, Takeda Pharmaceutical Co, a Japanese company, has enrolled their first patient in a worldwide clinical trial of COVID-19 blood plasma treatment after a regulatory delay of a few months.

In recent months, plasma therapy has been used in in China and South Korea. The verdict is not yet out. Having said that there has been a proliferation of research studies and clinical trials at hospitals efficacy of convalescent plasma as an emergency therapy, since there is a marked lack of potentially effective antiviral therapies against COVID-19. This is propelling the strides in the plasms therapy market. In some cases, particularly in severely ill with COVID-19, plasma therapy is considered as the only hope. Donation of plasma is done from fully recovered patients by plasmapheresis, and transfusion of separated plasma from whole blood of such patients.The study offers a critical assessment of key growth dynamics, emerging clinical avenues, investment trends in key regional markets, and the competitive landscape in various regions, and strategies of top players. The assessments also offer insight into the share and size of various segments in the plasma therapy market.

On another instance, GC Pharma claims the successful completion of their plasma therapy for COVID-19 called GC5131A. Such efforts will not only aid in expansion of the market but may also help come with a solution to fight coronavirus in the days to come.

Get Table of Content of the Report @

In terms of the plasma therapy market based on geography, Asia Pacific and North America stands as the most potential regions for growth. This is owing to the increasing cardinal growth prospects, rapid adoption of technology, and increasing number of clinical trials for COVID-19 in the respective regions. China stands as the leading nation promoting the global plasma therapy market growth. Besides this, the rising cases of orthopedic disorders, arthritis, and increasing demand for orthopedic disorders are likely to help this market gain significant shares in the years to come.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site:

Back to news